April 27, 2020 News by Joana Carvalho, PhD US Grants Patent to MedRhythms’ Proprietary Audio Engine Used in Walking Therapy Products The United States Patent and Trademark Office has issued a patent covering the intellectual rights to MedRhythms’ proprietary audio engine, a core component of the company’s rhythmic sound products designed to improve the walking ability of adult patients with multiple sclerosis (MS) and other neurological disorders. The…
January 21, 2020 News by Iqra Mumal, MSc Endonovo Therapeutics Issued Broad US Patent Covering Electromagnetic Treatment for MS The United States Patent and Trademark Office (USPTO) has issued a patent to Endonovo Therapeutics for Application No. 15/549,748, which covers the company’s technique and device for electromagnetic treatment of multiple sclerosis (MS). Endonovo has a pipeline of “Electroceuticals” — wearable, electronic, non-invasive therapeutic devices. These devices…
January 8, 2018 News by Patricia Silva, PhD MMJ Files Patent on Part-cannabinoid and Part-non-cannabinoid Treatment for MS MMJ International Holdings is seeking a patent for a part-cannabinoid and part-non-cannabinoid treatment for multiple sclerosis and other diseases. The company said in a news release that it filed the patent request ahead of Phase 2 clinical trials of the formulation. The therapy was developed by MMJ Bioscience, an affiliate of MMJ International…
March 21, 2017 News by Patricia Silva, PhD Kadimastem Obtains US Patent for Neurodegenerative Disease Stem Cell Technology The United States has granted a patent to Kadimastem’s stem cell-based technology for treating multiple sclerosis (MS) and other diseases of the nervous system. The patent involves the technology the company used to produce supporting cells in the central nervous system derived from human stem cells, including myelin-producing cells. The United…
November 18, 2016 News by Patricia Silva, PhD AXIM Biotech to Get U.S. Patent Covering All Cannabinoids in Its Chewing Gums AXIM Biotechnologies announced that the United States Patent and Trademark Office (USPTO) will be issuing a patent covering all cannabinoids — both natural and synthetic — used in a chewing gum delivery system that may be included in its cannabinoid-containing, controlled-release chewing gum products. The USPTO has given the company a Notice of…
February 12, 2016 News by Margarida Azevedo, MSc RedHill’s Experimental MS Therapy, RHB-104, Receives Notice of Allowance on U.S. Patent RedHill Biopharma, Ltd., an Israeli biopharmaceutical company focused on the development and commercialization of oral-administered small-molecule medicines for the treatment of inflammatory and gastrointestinal diseases, recently announced it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for a new patent covering its…
